Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
24.17
+0.12 (0.50%)
At close: Jun 12, 2026, 4:00 PM EDT
24.55
+0.38 (1.57%)
After-hours: Jun 12, 2026, 7:50 PM EDT

Elanco Animal Health Stock Forecast

Stock Price Forecast

According to 17 analysts polled by S&P Global, Elanco Animal Health stock has a consensus rating of "Strong Buy" and an average price target of $29.79. The average 1-year stock price forecast is 23.25% higher than the current stock price, while the lowest is $23 (-4.84%) and the highest is $32 (+32.40%).

Price Target: $29.79 (+23.25%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$23$29.79$30$32
Change-4.84%+23.25%+24.12%+32.40%

Analyst Ratings

The average analyst rating for Elanco Animal Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy91010111111
Buy444454
Hold322212
Sell111000
Strong Sell000000
Total171717171717

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 3, 2026
Morgan Stanley
Morgan Stanley
Hold
Maintains
$23
HoldMaintains$23-4.84%Jun 3, 2026
Barclays
Barclays
Buy
Maintains
$30
BuyMaintains$30+24.12%May 29, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Reiterates
n/a
BuyReiteratesn/an/aMay 22, 2026
Evercore ISI
Evercore ISI
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 11, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
5.05B
from 4.72B
Increased by 7.10%
Revenue Next Year
5.32B
from 5.05B
Increased by 5.33%
EPS This Year
1.06
from 0.94
Increased by 12.54%
EPS Next Year
1.19
from 1.06
Increased by 12.04%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
4.76B4.41B4.42B4.44B4.72B5.05B
Revenue Growth
45.64%-7.41%0.14%0.50%6.22%7.10%
Gross Profit
2.70B2.50B2.49B2.44B2.59B2.81B
Gross Margin
56.59%56.63%56.28%54.88%54.99%55.60%
Operating Income
376.00M390.00M331.00M257.00M259.00M855.07M
Net Income
-483.00M-78.00M-1.23B338.00M-232.00M45.06M
EPS
----0.941.06
EPS Growth
----3.30%12.54%
Forward PE
24.5512.6717.6413.7823.4822.85
Free Cash Flow
792.50M316.13M395.13M941.38M559.75M447.67M
No. Analysts
-----14
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High5.1B
Avg5.0B
Low5.0B

Revenue Growth

Revenue Growth202620272028
High
7.8%
Avg
7.1%
Low
5.4%

EPS Forecast

EPS202620272028
High1.09
Avg1.06
Low1.02

EPS Growth

EPS Growth202620272028
High
15.7%
Avg
12.5%
Low
8.5%